Stay updated on Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.

Latest updates to the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record history now shows a new revision entry (v3.4.2) and the previous revision (v3.4.1) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedNew revision version 3.4.1 was added to the record history, replacing the previous 3.4.0 revision. This is a metadata update reflecting version control rather than changes to study information.SummaryDifference0.1%

- Check27 days agoChange DetectedThe Record History page adds a Show glossary option and green/red highlights for additions and deletions. It also updates to Revision v3.4.0 and adjusts the No FEAR Act Data label.SummaryDifference1%

- Check42 days agoChange DetectedRevision history shows a new site release (v3.3.4) added and the previous release (v3.3.3) removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the Record History. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the history.SummaryDifference0.2%

- Check91 days agoChange DetectedAdded Revision: v3.3.2 to the study record versions; removed Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.